KILLINGTYPHI · Identification of host-factors restricting Salmonella Typhi
Horizon 2020 — Marie Skłodowska-Curie Actions
- Duration
- 2016-04-01 → 2018-03-31
- EU contribution
- €183,455
- Participants
- 1
- Scheme
- MSCA-IF-EF-ST
Lines connect the coordinator with its partners.
Results in brief
Identification of host-factors restricting Salmonella Typhi
Salmonella enterica serovar Typhi (S. Typhi) is one of the thousands of Salmonella types that exists. In contrast to other Salmonella species that can infect a broad range of vertebrate hosts and cause self-limited gastrointestinal infections in humans, S. Typhi is an unique serovar only able to infects humans (host-restriction). This bacterium causes a life-threatening systemic disease known as typhoid fever that affects more than 26 million people and kills over 200,000 patients annually. Typhoid is acquired by consumption of contaminated water or food washed in contaminated water and the incidence is particularly high in developing countries, where the disease spreads widely due to poor water sanitation and hygiene conditions. Natural disasters such as flooding or earthquakes can dramatically increase the risk of typhoid epidemics. Although this illness is commonly associated with low income regions, there are cases of typhoid in Western countries. These cases are associated with traveller returning from areas where typhoid is common. After antimicrobial treatment, some patients (called carriers) continue to, asymptomatically, carry and to spread S. Typhi being a source of infection for other people. Current typhoid vaccines have limitations, since they do not provide complete protection or lasting immunity. In addition, multidrug resistant S. Typhi are spreading globally making this illness almost untreatable in many areas of the planet. For all of this, typhoid is a global health problem and it is urgent to identify novel therapeutics to treat this disease. This requires a better understanding on how the host responds to S. Typhi infection and how the bacterium overcomes host defences. S. Typhi can live inside macrophages - cells of the immune system devoted to kill pathogens. Unlike human macrophages, macrophages from animals are able to clear S. Typhi. In 2012 Spanò and Galán identified two molecules in mice that are essential to kill S. Typhi. In spite of this, the exact killing mechanisms used by macrophages remain unknown. The overall objective of this project was to identify all the mechanisms that the macrophage uses to fight S. Typhi infection. For this, our first aim was to optimize the conditions for a large genome scale analysis in a smaller scale, targeting gene families that are known to be exploited by Salmonella and other bacterial pathogens to cause disease. In addition, we chose factors known to have an impact in the survival of bacterial pathogens in macrophages and evaluated their role in the outcome of S. Typhi infection.
Data: CORDIS, © European Union
Project objective
Typhoid fever is a life-threatening systemic infection that continues to be a serious global health concern, claiming the lives of over 200,000 patients every year. It is caused by the intracellular bacterium Salmonella Typhi, a human-adapted pathogen unable to infect species others than humans. The molecular mechanisms underlying S. Typhi infection are only partially understood. Spanò and Galán recently discovered an antimicrobial pathway that is required to restrict the growth of S. Typhi macrophages derived from mouse (a non-susceptible host) and contributes to S. Typhi host-restriction. Despite this finding, the exact mechanisms used by macrophages to kill S. Typhi as well as the role of these mechanisms in the adaptation to the human host remain unknown. Through this project, I will investigate the mechanisms used by non-permissive hosts to eliminate S. Typhi. I will combine my strong background in molecular microbiology with the world-renowned expertise of S. Typhi-host interactions of the receiving group to identify host genes required to kill S. Typhi. I will apply state-of-the-art technologies, including pooled shRNA screens coupled to next-generation sequencing and the novel and powerful CRISPR/Cas9 technology, supported by a network of local and international collaborators. Specifically, I will: 1) identify Rab GTPases required for S. Typhi killing, 2) identify novel factors involved in pathogen killing through an unbiased genome-wide screen, and 3) elucidate the role of well-characterized antimicrobial factors in the Rab32-dependent killing of S. Typhi. The results will reveal new strategies of host-defence and will extend our knowledge of the host immunity mechanisms controlling the growth of intracellular pathogens. They have the potential to identify new therapeutic approaches to treat typhoid fever.
Original text from CORDIS.
Participants
- THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN · AberdeenCoordinatorUnited Kingdom
Links
Data: CORDIS, © European Union
